Key Highlights

  • Agilent's $0.255 quarterly Dividend has an October 6, 2026 ex-dividend date and is payable October 28 to shareholders of record.
  • Third-quarter Revenue was $1.88 billion, up 8.1% reported and 7.3% core, with GAAP Net Income of $362 million.
  • GAAP EPS was $1.28 versus $1.18, and non-GAAP EPS was $1.62, including a $0.06 net benefit from Tariff refunds.
  • Fiscal 2026 non-GAAP EPS guidance was raised to $6.18 to $6.21, with fourth-quarter revenue guidance of $1.98 billion to $2.00 billion.

Agilent Technologies, Inc.'s (NYSE:A) $0.255 quarterly dividend yields 0.61% and sits beside third-quarter GAAP EPS of $1.28 and non-GAAP EPS of $1.62. The company announced the dividend on September 16, 2026, at the same 25.5 cents declared in November 2025, February 2026 and May 2026. Agilent paid $0.248 per share in the third quarter of fiscal 2025.

Dividend Program and Shareholder Returns

Agilent declared a quarterly dividend of 25.5 cents per share on September 16, 2026, payable October 28 to all shareholders of record as of the close of Business on October 6. The initial release carried transposed dates, and the company issued a corrected release the same day.

The 10-Q reports cash dividends paid of $0.255 per share, or $72 million, in the three months ended July 31, 2026, and $0.765 per share, or $216 million, in the nine months. A year earlier the company paid $0.248 per share, or $71 million, and $0.744 per share, or $212 million. The company states that the timing and amounts of future dividends are subject to Board approval.

About the Company

Agilent is a global provider of analytical and clinical laboratory technologies, offering instruments, software, services and expertise to laboratory customers. The company, based in Santa Clara, California, generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide.

Financial Performance Behind the Payout

Agilent reported third-quarter revenue of $1.88 billion for the quarter ended July 31, 2026, up 8.1% reported and 7.3% on a core basis. Nine-month revenue was $5,511 million. Income from operations was $444 million versus $360 million.

GAAP net income was $362 million, or $1.28 per diluted share, versus $336 million, or $1.18. For the nine months, GAAP net income was $1,006 million, or $3.55 per diluted share, versus $869 million, or $3.05. Non-GAAP net income was $459 million, or $1.62 per share, versus $390 million, or $1.37.

The company repurchased and retired 612,270 shares for $78 million in the quarter and 2.212 million shares for $295 million in the nine months. Free Cash Flow was $439 million, per the earnings call.

Tariff Refunds Inside Non-GAAP Results

Non-GAAP net income of $459 million includes a $17 million net benefit from tariff refunds, equal to $0.06 per share. Excluding the refunds, the company reported non-GAAP EPS of $1.56 and a non-GAAP Operating Margin of 27.2%. Including them, the operating margin was 28.3%.

On the call, management cited pharma revenue growth of 12%, China growth of 9% and advanced therapeutics growth of about 30%.

Outlook

Agilent's fiscal 2026 guidance is revenue of $7.49 billion to $7.51 billion, or 5.8% to 6.0% core growth, and non-GAAP EPS of $6.18 to $6.21, which includes the $0.06 tariff-refund benefit. Fourth-quarter revenue guidance is $1.98 billion to $2.00 billion, or 5.2% to 6.2% core growth. Pharma and China revenue, the tariff-refund item and the pace of repurchases are among the measures reported alongside that guidance.